Acute hyperglycaemia: A 'new' risk factor during myocardial infarction

European Heart Journal

Volumn 26, Issue 4, 2005, Pages 328-331

  Ceriello, Antonio ^a  

^a UNIVERSITY OF UDINE   (Italy)

Author keywords

Hyperglycaemia; Insulin treatment; Myocardial infarction; Oxidative stress

Indexed keywords

3 NITROTYROSINE; FATTY ACID; FIBRINOGEN; FIBRINOPEPTIDE A; FREE RADICAL; GLUCOSE; INSULIN; PEROXYNITRITE; PROTHROMBIN;

ACUTE HEART INFARCTION; BLOOD CLOTTING; DIABETES MELLITUS; HEART LEFT VENTRICLE FUNCTION; HUMAN; HYPERGLYCEMIA; INFLAMMATION; INSULIN TREATMENT; MORTALITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK FACTOR; THROMBOPHILIA; THROMBOSIS;

ACUTE DISEASE; BLOOD GLUCOSE; HUMANS; HYPERGLYCEMIA; INSULIN; MYOCARDIAL INFARCTION; OXIDATIVE STRESS; RISK FACTORS;

EID: 14144255735     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1093/eurheartj/ehi049     Document Type: Review

References (64)

1. Capes SE, Hunt D, Malmberg K et al. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 2000;355: 773-778.
2. Norhammar A, Tenerz A, Nilsson G et al. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet 2002;359: 2140-2144.
3. Yudkin JS, Oswald GA. Stress hyperglycemia and cause of death in non-diabetic patients with myocardial infarction. Br Med J 1987;294:773.
4. Sewdarsen M, Vythilingum S, Jialal I et al. Prognostic importance of admission plasma glucose in diabetic and non-diabetic patients with acute myocardial infarction. Q J Med 1989;71:461-466.
5. Bellodi G, Manicardi V, Malavasi V et al. Hyperglycemia and prognosis of acute myocardial infarction in patients without diabetes mellitus. Am J Cardiol 1989;64:885-888.
6. O'Sullivan JJ, Conroy RM, Robinson K et al. In-hospital prognosis of patients with fasting hyperglycemia after first myocardial infarction. Diabetes Care 1991;14:758-760.
7. Mak KH, Mah PK, Tey BH et al. Fasting blood sugar level: a determinant for in-hospital outcome in patients with first myocardial infarction and without glucose intolerance. Ann Acad Med Singapore 1993;22:291-295.
8. Leor J, Goldbourt U, Reicher-Relss H et al. Cardiogenic shock complicating acute myocardial infarction in patients without heart failure on admission: incidence, risk factors, and outcome. SPRINT Study Group. Am J Med 1993;94:265-273.
9. Malmberg K. Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group. Br Med J 1997;314:1512-1515.
10. Wahab NN, Cowden EA, Pearce NJ et al. ICONS Investigators. Is blood glucose an independent predictor of mortality in acute myocardial infarction in the thrombolytic era? J Am Coll Cardiol 2002;40: 1748-1754.
11. Stranders I, Diamant M, van Gelder RE et al. Admission blood glucose level as risk indicator of death after myocardial infarction in patients with and without diabetes mellitus. Arch Intern Med 2004;164: 982-988.
12. Wong VW, Ross DL, Park K et al. Hyperglycemia: still an important predictor of adverse outcomes following AMI in the reperfusion era. Diabetes Res Clin Pract 2004;64:85-91.
13. Hadjadj S, Coisne D, Mauco G et al. Prognostic value of admission plasma glucose and HbA1c in acute myocardial infarction. Diabet Med 2004;21:305-310.
14. Gokhroo R, Mittal SR. Electrocardiographic correlates of hyperglycemia in acute myocardial infarction. Int J Cardiol 1989;22: 267-269.
15. Marfella R, Nappo F, De Angelis L et al. The effect of acute hyperglycaemia on QTc duration in healthy man. Diabetologia 2000;43: 571-575.
16. D'Amico M, Marfella R, Nappo F et al. High glucose induces ventricular instability and increases vasomotor tone in rats. Diabetolagia 2001;44:464-470.
17. Ishihara M, Inoue I, Kawagoe T et al. Impact of acute hyperglycemia on left ventricular function after reperfusion therapy in patients with a first anterior wall acute myocardial infarction. Am Heart J 2003;146:674-678.
18. Iwakura K, Ito H, Ikushima M, Kawano S et al. Association between hyperglycemia and the no-reflow phenomenon in patients with acute myocardial infarction. J Am Coll Cardiol 2003;41:1-7.
19. Kersten JR, Schmeling TJ, Orth KG et al. Acute hyperglycemia abolishes ischemia preconditioning in vivo. Am J Physiol 1998;275:H721-H725.
20. Poulsen SH, Jensen SE, Tei C et al. Value of the Doppler index of myocardial performance in the early phase of acute myocardial infarction. J Am Soc Echocardiogr 2000;13:723-730.
21. Baele G, Mussche M, Vermeire P. Serum fibrin-fibrinogen degradation products in acute myocardial infarction. Lancet 1972;1:689-690.
22. Chandler AB, Chapman I, Erhardt LR et al. Coronary thrombosis in myocardial infarction. Report of a workshop on the role of coronary thrombosis in the pathogenesis of acute myocardial infarction. Am J Cardiol 1974;34:823-833.
23. Oswald GA, Smith CC, Delamothe AP et al. Raised concentrations of glucose and adrenaline and increased in vivo platelet activation after myocardial infarction. Br Heart J 1988;59:663-671.
24. Ceriello A. Coagulation activation in diabetes mellitus: the role of hyperglycaemia and therapeutic prospects. Diabetologia 1993;36:1119-1125.
25. Jones RL, Peterson CM. Reduced fibrinogen survival in diabetes mellitus a reversible phenomenon. J Clin Invest 1979;63:485-493.
26. Ceriello A, Giugliano D, Quatraro A et al. Hyperglycemia may determine fibrinopeptide A plasma level increase in humans. Metabolism 1989;38:1162-1163.
27. Ceriello A, Giacomello R, Stel G et al. Hyperglycemia-induced thrombin formation in diabetes. The possible role of the oxidative stress. Diabetes 1995;44:924-928.
28. Ceriello A, Giugliano D, Quatraro A et al. Blood glucose may condition factor VII levels in diabetic and normal subjects. Diabetologia 1988;31:889-891.
29. Sakamoto T, Ogawa H, Kawano H et al. Rapid change of platelet aggregability in acute hyperglycemia. Detection by a novel laser-light scattering method. Thromb Haemost 2000;83:475-479.
30. Mulvihill NT, Foley JB. Inflammation in acute coronary syndromes. Heart 2002;87:201-204.
31. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999;340:115-126.
32. Neri Serneri GG, Prisco D, Martini F et al. Acute T-cell activation is detectable in unstable angina. Circulation 1997;95:1806-1812.
33. Marfella R, Siniscalchi M, Esposito K et al. Effects of stress hyperglycemia on acute myocardial infarction: role of inflammatory immune process in functional cardiac outcome. Diabetes Care 2003;26:3129-3135.
34. Marfella R, Esposito K, Giunta R et al. Circulating adhesion molecules in humans: role of hyperglycemia and hyperinsulinemia. Circulation 2000;101:2247-2251.
35. Esposito K, Nappo F, Marfella R et al. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation 2002;106:2067-2072.
36. Ceriello A, Quagliaro L, Piconi L et al. Effect of postprandial hypertriglyceridemia and hyperglycemia on circulating adhesion molecules and oxidative stress generation and the possible role of simvastatin treatment. Diabetes 2004;53:701-710.
37. De Caterina R. Endothelial dysfunctions: common denominators in vascular disease. Curr Opin Lipidol 2000;11:9-23.
38. Valgimigli M, Merli E, Malagutti P et al. Endothelial dysfunction in acute and chronic coronary syndromes: evidence for a pathogenetic role of oxidative stress. Arch Biochem Biophys 2003;420:255-261.
39. Iraculis E, Cequier A, Gomez-Hospital JA et al. Early dysfunction and long-term improvement in endothelium-dependent vasodilation in the infarct-related artery after thrombolysis. J Am Coll Cardiol 2002;4:257-265.
40. Giugliano D, Marfella R, Coppola L et al. Vascular effects of acute hyperglycemia in humans are reversed by L-arginine. Evidence for reduced availability of nitric oxide during hyperglycemia. Circulation 1997;95:1783-1790.
41. Williams SB, Goldfine AB, Timimi FK et al. Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo. Circulation 1998;97:1695-1701.
42. Heinecke JW. Oxidative stress: new approaches to diagnosis and prognosis in atherosclerosis. Am J Cardiol 2003;91(Suppl.):12A-16A.
43. Ceriello A. Acute hyperglycaemia and oxidative stress generation. Diabet Med 1997;14:S45-S49.
44. Marfella R, Verrazzo G, Acampora R et al. Glutathione reverses systemic hemodynamic changes by acute hyperglycemia in healthy subjects. Am J Physiol 1995;268:E1167-E1173.
45. Beckman JA, Goldfine AB, Gordon MB et al. Ascorbate restores endothelium-dependent vasodilation impaired by acute hyperglycemia in humans. Circulation 2001;103:1618-1623.
46. Ceriello A, Motz E, Giugliano D. Hypertension and ascorbic acid. Lancet 2000;355:1272-1273.
47. Ceriello A, Bortolotti N, Crescentini A et al. Antioxidant defenses are reduced during oral glucose tolerance test in normal and non-insulin dependent diabetic subjects. Eur J Clin Invest 1998;28:329-333.
48. Beckman JS, Koppenot WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 1996;271: C1424-C1437.
49. Shishehbor MH, Aviles RJ, Brennan ML et al. Association of nitrotyrosine levels with cardiovascular disease and modulation by statin therapy. JAMA 2003;289:1675-1680.
50. Pennathur S, Wagner JD, Leeuwenburgh C et al. A hydroxyl radical-like species oxidizes cynomolgus monkey artery wall proteins in early diabetic vascular disease. J Clin Invest 2001;107:853-860.
51. Ceriello A, Quagliaro L, D'Amico M et al. Acute hyperglycemia induces nitrotyrosine formation and apoptosis in perfused heart from rat. Diabetes 2002;51:1076-1082.
52. Marfella R, Quagliaro L, Nappo F et al. Acute hyperglycemia induces an oxidative stress in healthy subjects. J Clin Invest 2001;108: 635-636.
53. Ceriello A, Taboga C, Tonutti L et al. Evidence for an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycemia on endothelial dysfunction and oxidative stress generation. Effects of short- and long-term simvastatin treatment. Circulation 2002;106:1211-1218.
54. Malmberg K, Ryden L, Efendic S et al. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J Am Coll Cardiol 1995;26:57-65.
55. Malmberg K, Ryden L, Hamsten A et al. Effects of insulin treatment on cause-specific one-year mortality and morbidity in diabetic patients with acute myocardial infarction. DIGAMI Study Group. Diabetes Insulin-Glucose in Acute Myocardial Infarction. Eur Heart J 1996;17:1337-1344.
56. Malmberg K, Norhammar A, Wedel H et al. Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study. Circulation 1999;99: 2626-2632.
57. Frier BM. Diabetes and myocardial infarction. Diabetes Rev Int 1998;7:1-2.
58. Fisher BM. Diabetes mellitus and myocardial infarction: a time to act or a time to wait? Diabet Med 1998;15:275.
59. van der Horst IC, Zijlstra F, van't Hof AW et al. Zwolle Infarct Study Group. Glucose-insulin-potassium infusion in patients treated with primary angioplasty for acute myocardial infarction: the glucose-insulin-potassium study: a randomized trial. J Am Coll Cardiol 2003;42:784-791.
60. Oliver MF, Yates PA. Induction of ventricular arrhythmias by elevation of arterial free fatty acids in experimental myocardial infarction. Cardiology 1971;56:359-364.
61. Kurien VA, Yates PA, Oliver MF. The role of free fatty acids in the production of ventricular arrhythmias after acute coronary artery occlusion. Eur J Clin Invest 1971;1:225-241.
62. Ceriello A, Motz E. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler Thromb Vasc Biol 2004;24:816-823.
63. van den Berghe G, Wouters P, Weekers F et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001;345:1359-1367.
64. Van den Berghe G, Wouters PJ, Bouillon R et al. Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control. Crit Care Med 2003;31:359-366.